A collaborative study with Harvard Medical School
Working in Partnership with Nursing Home Sector to Facilitate Improved Wound Management with the Introduction of Bioactive Microfibre Gelling (BMG™) Technology
Publication Details:
Bentham, T. & Blount, B. (2023) Working in partnership with the nursing home sector to facilitate improved wound management with the introduction of Bioactive Microfibre Gelling (BMG™) technology. Wound Care Today, 2023.
Wound Details
The study focused on chronic wounds in nursing home patients, particularly category 3 sacral pressure ulcers that had been static and non-healing for six months.
Key Findings and Data:
- Wound One: Progressed from 10% slough, 5% necrosis, and 85% granulation to 100% granulation.
- Wound Two: Progressed from 5% slough and 95% granulation to 100% granulation.
- Exudate levels decreased from moderate-high to low, leading to improved wound bed conditions.
- Effectively debrided slough and necrotic tissue, particularly in wound one, exposing a well-defined wound bed that facilitated better wound management.
- All participating clinicians expressed willingness to continue using MaxioCel as a reliable, all-around wound care solution.
- Staff reported that the wound improvement was “amazing”, reinforcing the product’s effectiveness.
Key Insights
- MaxioCel demonstrated remarkable efficacy in wound healing, exudate management, and tissue regeneration in a challenging nursing home setting.
- The product’s ease of use, painless removal, and ability to maintain a clean wound bed make it an ideal choice for chronic wound management in long-term care facilities.
Related Publications
Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers
Chronic Wound Debridement in an Acute Setting
Severe Pressure Ulcer Debridement in the Acute Sector
A Multi-disciplinary Team Approach to the Management
